Kirk, P. S., Koreckij, T., Nguyen, H. M., Brown, L. G., Snyder, L. A., Vessella, R. L., & Corey, E. (2013). Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI).
Citação norma ChicagoKirk, Peter S., Theodore Koreckij, Holly M. Nguyen, Lisha G. Brown, Linda A. Snyder, Robert L. Vessella, and Eva Corey. Inhibition of CCL2 Signaling in Combination With Docetaxel Treatment Has Profound Inhibitory Effects On Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI), 2013.
Citação norma MLAKirk, Peter S., et al. Inhibition of CCL2 Signaling in Combination With Docetaxel Treatment Has Profound Inhibitory Effects On Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI), 2013.